Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00535964 · ClinicalTrials.gov registry record
Evaluating the Relationship Between Tobacco Use, Anxiety Sensitivity, and Panic in Adolescents
A clinical trial, sponsored by University of Arkansas, Fayetteville.
- Completed
- Registry status
- 180
- Enrollment target
NCT00535964: Completed study, sponsored by University of Arkansas, Fayetteville.
NCT00535964 is a clinical trial that has completed, run by University of Arkansas, Fayetteville. The registered enrollment target is 180 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00535964 has completed, sponsored by University of Arkansas, Fayetteville.
- COMPLETED
- Registry status
- 180 participants
- Enrollment target
Study Summary
This study will determine whether there is a relationship between tobacco use and a heightened response to panic-producing events among adolescents. This study is fundamental research. It was not a Clinical Trial.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2007-06 |
| Est. Completion | 2009-04 |
What the finished NCT00535964 record still lists
NCT00535964 is an observational study that tracks outcomes without assigning an intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00535964 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00535964 about?
NCT00535964 is a clinical study titled "Evaluating the Relationship Between Tobacco Use, Anxiety Sensitivity, and Panic in Adolescents". This study will determine whether there is a relationship between tobacco use and a heightened response to panic-producing events among adolescents. This study is fundamental research. It was not a Clinical Trial.
What is the current status of trial NCT00535964?
This trial is currently completed. The enrollment target is 180 participants. The study started on 2007-06. Estimated completion is 2009-04.
Who is sponsoring clinical trial NCT00535964?
This trial is sponsored by University of Arkansas, Fayetteville, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia